Barriers to Biologics Access

Jonathan Kay, MD, reviews the barriers related to access of biologics such as economic barriers, health inequities, or disparities.

Related Keywords

Jonathan Kay , ,Biosimilars Stakeholder Summit ,Interchangeable Biosimilars ,Inflammatory Diseases ,